{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:21:19Z","timestamp":1761513679579,"version":"3.40.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.yebeh.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,8,16]],"date-time":"2015-08-16T00:15:26Z","timestamp":1439684126000},"page":"166-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010"],"prefix":"10.1016","volume":"51","author":[{"given":"Gina M.","family":"Deck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-3347","authenticated-orcid":false,"given":"Neil","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia D.","family":"Montouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Lovett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2015.07.001_bb0005","first-page":"S21","article-title":"Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy","volume":"55","author":"Yerby","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0010","series-title":"Women with Epilepsy: a practical management handbook","first-page":"157","article-title":"Teratogenicity and antiepileptic drugs","author":"Montouris","year":"2014"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0015","first-page":"1","article-title":"Update on overall prevalence of major defects\u2014Atlanta, Georgia, 1978\u20132005","volume":"57","author":"Rynn","year":"2008","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0020","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ncl.2004.07.004","article-title":"Pregnancy in women who have epilepsy","volume":"22","author":"Pennell","year":"2004","journal-title":"Neurol Clin"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","article-title":"Practice parameter update: management issues for women with epilepsy\u2014focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0035","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMc1008255","article-title":"Valproic acid use in pregnancy and congenital malformations","volume":"363","author":"Vajda","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0045","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/j.1528-1157.1994.tb05952.x","article-title":"Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age","volume":"35","author":"Lindhout","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0050","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1586\/ern.12.32","article-title":"Second-generation antiepileptic drugs and pregnancy: a guide for clinicians","volume":"12","author":"Reimers","year":"2012","journal-title":"Expert Rev Neurother"},{"issue":"Suppl 2","key":"10.1016\/j.yebeh.2015.07.001_bb0055","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.yebeh.2003.07.002","article-title":"Medical comorbidities in the treatment of epilepsy","volume":"4","author":"Boro","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0065","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0070","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jpeds.2008.05.059","article-title":"Prevalence of congenital heart defects in Metropolitan Atlanta, 1998\u20132005","volume":"153","author":"Reller","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0075","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/bdra.20735","article-title":"Updated national birth prevalence estimates for selected birth defects in the United States, 2004\u20132006","volume":"88","author":"Parker","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0080","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/bdra.20051","article-title":"Clonazepam use in pregnancy and the risk of malformations","volume":"70","author":"Lin","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1701-2163(16)34772-7","article-title":"The fetal safety of benzodiazepines: an updated meta-analysis","volume":"33","author":"Enato","year":"2001","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.yebeh.2015.07.001_bb0090","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00004714-200108000-00017","article-title":"Maternal exposure to lorazepam and anal atresia in newborns: results for a hypothesis-generating study of benzodiazepines and malformations","volume":"21","author":"Bonnot","year":"2001","journal-title":"J Clin Psychopharmacol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015003844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015003844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T02:21:22Z","timestamp":1537410082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505015003844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":17,"alternative-id":["S1525505015003844"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.07.001","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}